Cosan disclosed in a regulatory filing with the CVM on Friday evening (Nov. 13) that Chief Executive Officer Marcelo Martins will step down on January 4, 2027. Guilherme Penin, currently Vice President of Strategy, will take over as interim CEO. The stock has not been delisted or suspended from trading: what changes is who leads the holding company as it seeks to sell assets to pay down debt.
CSAN3: What Happened?
According to the material fact filing, Cosan's Board of Directors, with support from the People Committee, approved the start of the CEO succession process during a regular meeting on November 13. Marcelo Eduardo Martins, a 20-year veteran of the group who returned to the CEO role in 2024, will see his resignation take effect on January 4, 2027. On the same date, Guilherme Penin will assume the presidency on an interim basis. Penin brings over 20 years of experience in the infrastructure sector and 10 years within the group.
The key detail for investors: Martins is not leaving the group. According to Cosan, he will retain his seats on the board of directors of the holding company as well as its main subsidiaries—Rumo, Compass, and Moove. In these roles, he will support his successor on "strategic matters" and M&A transactions (mergers, acquisitions, and divestitures). The company credited him with two recent milestones: the 2025 capitalization and leading Raízen's extrajudicial restructuring. According to InvestNews, that capitalization brought in BTG Pactual and Perfin as partners.
Penin takes over as interim CEO on January 4, 2027The regulatory filing does not set a timeline for selecting a permanent CEO
This is where the announcement remains silent. The document does not state whether Penin's role will become permanent, whether an external search will be conducted, or when a final decision will be reached. The company promises only that the process will be carried out "with the usual planning and transparency." But investors startled by searching for the stock need another answer first.
Was CSAN3 Delisted or Taken Private?
No. Nothing in the regulatory filing touches on going private, ticker changes, or trading suspensions. The stock closed at R$ 3.01 on Friday (Nov. 13), according to market data. The announcement was submitted to Brazil's securities regulator, the CVM, at 9:38 p.m., well after market close. Consequently, the market's initial reaction to the leadership change will only play out on Monday (Nov. 16).
If your brokerage platform does not show the asset, double-check the ticker. CSNA3 belongs to Companhia Siderúrgica Nacional, a common mix-up in search bars. The correct ticker is CSAN3. The CSAN3 stock price, dividends, and filings page details the asset's history. There, investors can track the magnitude of the sell-off: the stock has dropped 50.7% over 12 months, ranging from a 52-week high of R$ 6.90 to a low of R$ 2.16 over the period.
What Does the CEO Change Mean for the Sale of Rumo and Compass?
Very little in the short term, which is precisely what the company aimed to signal by retaining Martins on the subsidiary boards with the explicit mandate to oversee M&A. Moving out of the executive management role while remaining on the boards of all major subsidiaries keeps him at the table where divestitures are approved. These asset sales lie at the heart of the investment case, as the holding company carries a net debt to EBITDA ratio (earnings before interest, taxes, depreciation, and amortization) of 8.54x, compared to a five-year median of 3.65x.
| Front | Current Status | Who Oversees After Jan. 4 |
|---|---|---|
| Sale of Rumo stake | Confirmed talks; removing the 15% poison pill requires shareholder approval | Martins on Rumo and Cosan boards; Penin leading executive team |
| Sale of 25% Compass stake | No agreement signed or approved, per Nov. 9 disclosure | Martins on Compass board |
| Radar land holdings | Sold for R$ 808 million in November | Completed |
| Tax dispute settlement | Reduces ~R$ 3.2B in contingencies for ~R$ 200M net outlay; awaiting ratification | Executive team (Penin and CFO) |
Two of these fronts were previously analyzed: the talks to sell a stake in Rumo and the poison pill hurdle, alongside Cosan's response to stock exchange operator B3 regarding the Compass stake. The CEO transition does not alter the status of either transaction. However, it introduces execution risk: the new CEO takes over while negotiations for Rumo are underway while holding an interim title. Buyers on the other side of the table may want to know who holds long-term signing authority. In Penin's favor, Cosan noted that he "already actively participates in strategic decisions" across the portfolio. As VP of Strategy, he was already involved in these initiatives.
Why are these sales so urgent? The answer lies in the earnings report published the same day.
Q3 2026 Results Highlight the Urgency
Cosan released its third-quarter earnings report just hours before the executive announcement. Net income reached R$ 190 million, reversing a net loss from the same period in 2025. Equity in earnings of affiliates—the portion of subsidiary profits flowing to the holding company—surged to R$ 719 million, up R$ 1.2 billion compared to Q3 2025. Administrative expenses at the holding level fell by R$ 11 million to R$ 54 million. However, expanded net debt increased 3% from Q2 2026 to R$ 9.5 billion, up from approximately R$ 9.2 billion in the previous quarter.
The most concerning figure is the Debt Service Coverage Ratio (DSCR), which measures how much of its debt service (interest and principal repayments) the holding company can cover with incoming cash flow. DSCR came in at 0.3x, compared to 0.2x in the prior quarter, whereas management targets a range of 0.8x to 1.2x for December 2026.
Moving from 0.3x to at least 0.8x in a single quarter requires nearly tripling the cash available for debt service or reducing debt service costs by a similar proportion. Reaching that target depends heavily on subsidiary dividends and proceeds from asset sales. This will serve as the first test of credibility for the leadership in transition: if the company misses its December target, the market may view the executive change as part of the operational strain rather than a seamless transition.
Does CSAN3 Pay Dividends?
It has not paid dividends since 2024. The last distribution, according to B3 data, was R$ 0.4515 per share, going ex-dividend on June 6, 2024. Since then, the company posted full-year net losses in both 2024 and 2025, with trailing 12-month net losses reaching R$ 8.9 billion through Q2 2026. While the Q3 2026 net profit is a positive step, as long as holding-level cash flow fails to cover basic debt service, any executive team's priority will remain servicing debt rather than paying dividends.
For existing positions, nothing changes automatically: trading continues as normal and the transition only takes effect in January. The core investment thesis remains intact, continuing to hinge on asset sales at valuations sufficient to pay down debt, with key negotiators (Martins, now via board seats) remaining involved. However, leadership uncertainty increases, as an interim CEO without a set timeline for confirmation or replacement steps in during the most critical restructuring process of the year.
What Is Preserved and What Remains Open
- Martins retains his board seats at Cosan, Rumo, Compass, and Moove, focusing directly on M&A.
- Penin transitions from the Strategy office after participating in major portfolio decisions, mitigating execution risk.
- The transition schedule provides over seven weeks between announcement and effective date, suggesting an orderly handover.
- There is no established timeline or explicit criteria for selecting a permanent CEO.
- The handover takes place while the debt coverage ratio stands at 0.3x, far below the company's December target.
- The filing did not disclose specific reasons for the leadership departure beyond acknowledging Martins' contributions.
The stock had been undergoing a solid recovery off its lows. As covered in the analysis of UBS-BB's R$ 4.70 price target, the stock closed at R$ 2.77 on November 6; Friday's closing price sits 8.7% above that mark. To sustain this momentum, investors will need to see asset sales progress—a process the executive transition could either maintain or delay.
Key Factors to Watch Ahead of January
Trading on Monday (Nov. 16) — A sharp decline beyond typical volatility would indicate the market views the CEO departure as a risk to planned asset sales.
Rumo poison pill vote — A shareholder meeting called before Jan. 4 would signal that the Rumo transaction remains on schedule despite executive changes.
December DSCR metric — Management's internal target sits between 0.8x and 1.2x; a reading below 0.8x points to delays in the deleveraging timeline.
Permanent CEO updates — Confirming Penin indicates long-term strategy continuity; initiating an external search opens a secondary transition phase in 2027.
Raízen, which ceased to be consolidated as a Cosan subsidiary following the restructuring led by Martins, highlights how critical execution is to share price performance, as explored in why RAIZ4 shares declined in October.